Hitinder S. Gurm, MBBS, MD, FSCAI

Original Contribution

Root Cause Analysis of Deaths in ST-Segment Elevation Myocardial Infarctions Treated with Primary PCI: What Can We Do Better?

03/15/2017

Fredy El Sakr , MD;

Mohamad Kenaan , MD;

Daniel Menees , MD;

Milan Seth , BS, MS;

Hitinder S. Gurm , MBBS, MD, FSCAI;

Recent data demonstrate that mortality of patients with ST-elevation myocardial infarction (STEMI) has not changed despite dramatic reduction in door-to-balloon times. Identifying potential areas in care that can be further optimized to...

Recent data demonstrate that...

03/15/2017

Journal of Invasive Cardiology

Original Contribution

Contemporary Trends and Outcomes Associated With the Preprocedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

04/15/2017

Milan Seth , BS, MS;

Hitinder S. Gurm , MBBS, MD, FSCAI;

Devraj Sukul , MD;

Akshay Khandelwal , MD;

Simon R. Dixon , MBChB, FACC, FRACP, MD;

Thomas A. LaLonde , MD;

We sought to describe trends in the use of preprocedural P2Y12 inhibitors and their clinical impact in patients undergoing percutaneous coronary intervention (PCI).

We sought to describe trends in...

04/15/2017

Journal of Invasive Cardiology